Author

B. J. Eduful

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

C. I. Wells· 2 shared A. d. S. Santiago· 1 shared A. U. Schirmer· 1 shared C. G. Langendorf· 1 shared D. Drewry· 1 shared D. H. Drewry· 1 shared E. Macias· 1 shared G. R. Devi· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

C. I. Wells

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivFeb 21, 2021

Non-canonical role of Hippo tumor suppressor serine/threonine kinase 3 STK3 in prostate cancer

A. U. Schirmer, L. M. Driver, M. T. Zhao…·E. Macias

This study shows that STK3, typically a tumor suppressor, promotes prostate cancer growth and identifies STK3 inhibitors with therapeutic potential.

DOI 10.1016/j.ymthe.2021.08.029

humanexperimental assay

Cancer BiologybioRxivJan 8, 2020

In depth analysis of kinase cross screening data to identify CAMKK2 inhibitory scaffolds

S. O'Byrne, J. W. Scott, J. R. Pilotte…·D. H. Drewry

This paper reviews CAMKK2's role in biology and disease, identifies starting points for inhibitor development using literature and databases, and highlights potential for selective inhibitors in oncology, metabolism, and inflammation.

DOI 10.3390/molecules25020325

experimental assay